Skip to content

Assess the Effect of Erythromycin on the Rate of Success in Placement of a Self-propelled Feeding Tube

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00999232
Enrollment
Unknown
Registered
2009-10-21
Start date
2004-10-31
Completion date
Unknown
Last updated
2010-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatitis

Keywords

erythromycin, prokinetics, nasojejunal tubes, Bengmark feeding tube, post-pyloric feeding, pancreatitis, Non-critically ill patients having pancreatitis who require jejunal enteral nutrition

Brief summary

The purpose of this study is to assess the effect of erythromycin on the Rate of Success in Placement of a Self-propelled Feeding Tube.

Interventions

DRUGErythromycin

Subjects receive 4x250mg erythromycin i.v. daily after intubation of a self-propelled feeding tube

DRUGPlacebo

Subjects receive 4x placebo i.v. daily after intubation of a self-propelled feeding tube

Sponsors

Canisius-Wilhelmina Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Aged 18-80 years * Having pancreatitis * Require jejunal enteral nutrition

Exclusion criteria

* Known impaired peristalsis (critically ill patients, postoperative patients, history of surgery of the stomach/duodenum) * Pregnancy * Hypersensibility to erythromycin * Cardiac arrhythmias with a prolonged QT-time * Simultaneous usage of drugs impairing peristalsis

Design outcomes

Primary

MeasureTime frame
The success rate of spontaneous positioning the tubes tip into the jejunum, beyond Treitz ligament, after 48 hours.

Secondary

MeasureTime frame
The success rate of spontaneous positioning the tubes tip into the jejunum, beyond Treitz ligament, after 24 hours.
Adverse events using this self-propelled tube

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026